DiaMedica Therapeutics (DMAC) Earnings Date, Estimates & Call Transcripts → He Is Giving Away Bitcoin (From Crypto Swap Profits) (Ad) Free DMAC Stock Alerts $2.45 +0.03 (+1.24%) (As of 04/24/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateMay. 20EstimatedActual EPS (Mar. 20) -$0.14 Consensus EPS (Mar. 20) -$0.14 Read Call TranscriptListen to Call Get DiaMedica Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for DMAC and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueDMAC Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.DMAC Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Paradigm PressBiden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.See his shocking evidence in this new report DiaMedica Therapeutics Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($0.69) EPSDMAC Earnings Date and InformationDiaMedica Therapeutics last announced its earnings data on March 20th, 2024. The reported ($0.14) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.14). DiaMedica Therapeutics has generated ($0.62) earnings per share over the last year (($0.62) diluted earnings per share). DiaMedica Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 20th, 2024 based off prior year's report dates.Read More DiaMedica Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/20/2024Estimated)------- 3/20/2024-($0.14)($0.14)-($0.14)-- 11/13/2023Q3 2023($0.14)($0.12)+$0.02($0.12)--8/14/2023Q2 2023($0.22)($0.16)+$0.06($0.16)--5/15/2023Q1 2023($0.16)($0.20)($0.04)($0.20)--3/28/2023Q4 2022($0.14)($0.14)-($0.14)-- 11/9/2022Q3 2022($0.13)($0.12)+$0.01($0.12)-- Get the Latest News and Ratings for DMAC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for DiaMedica Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/10/2022Q2 2022($0.16)($0.13)+$0.03($0.13)-- 5/4/2022Q1 2022($0.20)($0.13)+$0.07($0.13)-- 3/14/2022Q4 2021($0.16)($0.10)+$0.06($0.10)-- 11/10/2021Q3 2021($0.23)($0.18)+$0.05($0.18)-- 8/11/2021Q2 2021($0.19)($0.17)+$0.02($0.17)-- 5/5/2021Q1 2021($0.23)($0.19)+$0.04($0.19)-- DiaMedica Therapeutics Earnings - Frequently Asked Questions When is DiaMedica Therapeutics's earnings date? DiaMedica Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 20th, 2024 based off last year's report dates. Learn more on DMAC's earnings history. Did DiaMedica Therapeutics beat their earnings estimates last quarter? In the previous quarter, DiaMedica Therapeutics (NASDAQ:DMAC) reported ($0.14) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.14). Learn more on analysts' earnings estimate vs. DMAC's actual earnings. How can I listen to DiaMedica Therapeutics's earnings conference call? The conference call for DiaMedica Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How can I read DiaMedica Therapeutics's conference call transcript? The conference call transcript for DiaMedica Therapeutics's latest earnings report can be read online. Read Transcript How much profit does DiaMedica Therapeutics generate each year? DiaMedica Therapeutics (NASDAQ:DMAC) has a recorded net income of -$19.38 million. DMAC has generated -$0.62 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Related Companies: Allakos Earnings Date Reviva Pharmaceuticals Earnings Date Aclaris Therapeutics Earnings Date Milestone Pharmaceuticals Earnings Date Clearside Biomedical Earnings Date Genelux Earnings Date Seres Therapeutics Earnings Date Oramed Pharmaceuticals Earnings Date PMV Pharmaceuticals Earnings Date Chimerix Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted This page (NASDAQ:DMAC) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsThe #1 Biotech Stock to Have on Your Radar in 2024… Huge AlertsFed launches fourth dollar overhaulStansberry ResearchThe #1 Crypto for 2024InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DiaMedica Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
